Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ICUI's Cash to Debt is ranked higher than
96% of the 308 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. ICUI: No Debt )
ICUI' s 10-Year Cash to Debt Range
Min: 1.75   Max: No Debt
Current: No Debt

Equity to Asset 0.94
ICUI's Equity to Asset is ranked higher than
98% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. ICUI: 0.94 )
ICUI' s 10-Year Equity to Asset Range
Min: 0.85   Max: 0.96
Current: 0.94

0.85
0.96
Interest Coverage No Debt
ICUI's Interest Coverage is ranked higher than
98% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.96 vs. ICUI: No Debt )
ICUI' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 5
Z-Score: 19.59
M-Score: -2.96
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 16.56
ICUI's Operating margin (%) is ranked higher than
86% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.30 vs. ICUI: 16.56 )
ICUI' s 10-Year Operating margin (%) Range
Min: 7.83   Max: 34.17
Current: 16.56

7.83
34.17
Net-margin (%) 12.88
ICUI's Net-margin (%) is ranked higher than
86% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.08 vs. ICUI: 12.88 )
ICUI' s 10-Year Net-margin (%) Range
Min: 6.62   Max: 22.42
Current: 12.88

6.62
22.42
ROE (%) 8.70
ICUI's ROE (%) is ranked higher than
76% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. ICUI: 8.70 )
ICUI' s 10-Year ROE (%) Range
Min: 3.2   Max: 14.42
Current: 8.7

3.2
14.42
ROA (%) 8.09
ICUI's ROA (%) is ranked higher than
84% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. ICUI: 8.09 )
ICUI' s 10-Year ROA (%) Range
Min: 3.03   Max: 13.57
Current: 8.09

3.03
13.57
ROC (Joel Greenblatt) (%) 32.80
ICUI's ROC (Joel Greenblatt) (%) is ranked higher than
85% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.70 vs. ICUI: 32.80 )
ICUI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 9.36   Max: 69.49
Current: 32.8

9.36
69.49
Revenue Growth (%) 0.20
ICUI's Revenue Growth (%) is ranked higher than
65% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. ICUI: 0.20 )
ICUI' s 10-Year Revenue Growth (%) Range
Min: 0.2   Max: 34.6
Current: 0.2

0.2
34.6
EBITDA Growth (%) -0.10
ICUI's EBITDA Growth (%) is ranked higher than
65% of the 231 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.10 vs. ICUI: -0.10 )
ICUI' s 10-Year EBITDA Growth (%) Range
Min: -19.8   Max: 35.1
Current: -0.1

-19.8
35.1
EPS Growth (%) 7.10
ICUI's EPS Growth (%) is ranked higher than
74% of the 237 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.10 vs. ICUI: 7.10 )
ICUI' s 10-Year EPS Growth (%) Range
Min: -32.2   Max: 66
Current: 7.1

-32.2
66
» ICUI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

ICUI Guru Trades in Q2 2013

Mariko Gordon 550,761 sh (New)
Mario Gabelli 27,333 sh (+22.39%)
Jim Simons 253,600 sh (+4.75%)
Joel Greenblatt Sold Out
Paul Tudor Jones 5,900 sh (-35.87%)
Chuck Royce 23,300 sh (-44.12%)
John Hussman 14,000 sh (-48.15%)
» More
Q3 2013

ICUI Guru Trades in Q3 2013

Steven Cohen 9,814 sh (New)
Mario Gabelli 48,033 sh (+75.73%)
Jim Simons 394,600 sh (+55.6%)
Paul Tudor Jones 9,000 sh (+52.54%)
John Hussman Sold Out
Mariko Gordon Sold Out
Chuck Royce 16,300 sh (-30.04%)
» More
Q4 2013

ICUI Guru Trades in Q4 2013

Joel Greenblatt 133,533 sh (New)
Paul Tudor Jones 15,959 sh (+77.32%)
Jim Simons 598,500 sh (+51.67%)
Mario Gabelli 69,733 sh (+45.18%)
Steven Cohen Sold Out
Chuck Royce 700 sh (-95.71%)
» More
Q1 2014

ICUI Guru Trades in Q1 2014

Steven Cohen 3,930 sh (New)
Joel Greenblatt 242,621 sh (+81.69%)
Mario Gabelli 115,000 sh (+64.91%)
Jim Simons 732,201 sh (+22.34%)
Chuck Royce 700 sh (unchged)
Paul Tudor Jones 4,115 sh (-74.22%)
» More
» Details

Insider Trades

Latest Guru Trades with ICUI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 Add 81.69%0.1%$56.75 - $66.2 $ 59.75-3%242621
Mario Gabelli 2014-03-31 Add 64.91%0.01%$56.75 - $66.2 $ 59.75-3%115000
Joel Greenblatt 2013-12-31 New Buy0.2%$60.86 - $68.32 $ 59.75-7%133533
Mario Gabelli 2013-12-31 Add 45.18%0.01%$60.86 - $68.32 $ 59.75-7%69733
Mariko Gordon 2013-09-30 Sold Out 1.9%$67.84 - $75.9 $ 59.75-16%0
John Hussman 2013-09-30 Sold Out 0.05%$67.84 - $75.9 $ 59.75-16%0
Mario Gabelli 2013-09-30 Add 75.73%0.01%$67.84 - $75.9 $ 59.75-16%48033
Mariko Gordon 2013-06-30 New Buy1.9%$58.34 - $75.7 $ 59.75-10%550761
Joel Greenblatt 2013-06-30 Sold Out 0.13%$58.34 - $75.7 $ 59.75-10%0
John Hussman 2013-06-30 Reduce -48.15%0.03%$58.34 - $75.7 $ 59.75-10%14000
Mario Gabelli 2013-06-30 Add 22.39%$58.34 - $75.7 $ 59.75-10%27333
John Hussman 2013-03-31 New Buy0.06%$56.07 - $63.91 $ 59.750%27000
Joel Greenblatt 2012-03-31 Add 68.36%0.08%$44.41 - $49.53 $ 59.7537%44727
Joel Greenblatt 2011-12-31 Add 74.83%0.06%$35.99 - $45.53 $ 59.7544%26566
Joel Greenblatt 2011-09-30 Add 59.36%0.03%$36.41 - $45.79 $ 59.7547%15195
Joel Greenblatt 2011-06-30 New Buy0.06%$41.23 - $45.21 $ 59.7538%9535
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about ICU Medical Inc

Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 24.00
ICUI's P/E(ttm) is ranked higher than
84% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 35.10 vs. ICUI: 24.00 )
ICUI' s 10-Year P/E(ttm) Range
Min: 13.77   Max: 106.63
Current: 24

13.77
106.63
P/B 1.90
ICUI's P/B is ranked higher than
82% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. ICUI: 1.90 )
ICUI' s 10-Year P/B Range
Min: 1.4   Max: 3.45
Current: 1.9

1.4
3.45
P/S 2.94
ICUI's P/S is ranked higher than
71% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. ICUI: 2.94 )
ICUI' s 10-Year P/S Range
Min: 1.73   Max: 6.58
Current: 2.94

1.73
6.58
PFCF 19.10
ICUI's PFCF is ranked higher than
92% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 83.00 vs. ICUI: 19.10 )
ICUI' s 10-Year PFCF Range
Min: 11.24   Max: 98.42
Current: 19.1

11.24
98.42
EV-to-EBIT 11.88
ICUI's EV-to-EBIT is ranked higher than
93% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.19 vs. ICUI: 11.88 )
ICUI' s 10-Year EV-to-EBIT Range
Min: 7   Max: 71.3
Current: 11.88

7
71.3
PEG 3.30
ICUI's PEG is ranked higher than
85% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.00 vs. ICUI: 3.30 )
ICUI' s 10-Year PEG Range
Min: 0.6   Max: 158.4
Current: 3.3

0.6
158.4
Shiller P/E 23.60
ICUI's Shiller P/E is ranked higher than
93% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 23.60 )
ICUI' s 10-Year Shiller P/E Range
Min: 16.32   Max: 37.97
Current: 23.6

16.32
37.97
Current Ratio 15.71
ICUI's Current Ratio is ranked higher than
97% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.79 vs. ICUI: 15.71 )
ICUI' s 10-Year Current Ratio Range
Min: 5.86   Max: 23.06
Current: 15.71

5.86
23.06
Quick Ratio 14.28
ICUI's Quick Ratio is ranked higher than
97% of the 302 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. ICUI: 14.28 )
ICUI' s 10-Year Quick Ratio Range
Min: 4.57   Max: 22
Current: 14.28

4.57
22

Valuation & Return

vs
industry
vs
history
Price/Net Cash 3.30
ICUI's Price/Net Cash is ranked higher than
96% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 3.30 )
ICUI' s 10-Year Price/Net Cash Range
Min: 2.24   Max: 575
Current: 3.3

2.24
575
Price/Net Current Asset Value 2.80
ICUI's Price/Net Current Asset Value is ranked higher than
96% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 2.80 )
ICUI' s 10-Year Price/Net Current Asset Value Range
Min: 2.05   Max: 83.33
Current: 2.8

2.05
83.33
Price/Tangible Book 1.90
ICUI's Price/Tangible Book is ranked higher than
89% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.06 vs. ICUI: 1.90 )
ICUI' s 10-Year Price/Tangible Book Range
Min: 1.37   Max: 4.51
Current: 1.9

1.37
4.51
Price/DCF (Projected) 1.20
ICUI's Price/DCF (Projected) is ranked higher than
93% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.03 vs. ICUI: 1.20 )
ICUI' s 10-Year Price/DCF (Projected) Range
Min: 0.79   Max: 2.63
Current: 1.2

0.79
2.63
Price/Median PS Value 1.00
ICUI's Price/Median PS Value is ranked higher than
78% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.11 vs. ICUI: 1.00 )
ICUI' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 2.45
Current: 1

0.6
2.45
Price/Peter Lynch Fair Value 2.90
ICUI's Price/Peter Lynch Fair Value is ranked higher than
88% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ICUI: 2.90 )
ICUI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.62   Max: 13.02
Current: 2.9

0.62
13.02
Price/Graham Number 1.40
ICUI's Price/Graham Number is ranked higher than
91% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.73 vs. ICUI: 1.40 )
ICUI' s 10-Year Price/Graham Number Range
Min: 0.92   Max: 3.55
Current: 1.4

0.92
3.55
Earnings Yield (Greenblatt) 8.30
ICUI's Earnings Yield (Greenblatt) is ranked higher than
86% of the 252 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.20 vs. ICUI: 8.30 )
ICUI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.4   Max: 14.4
Current: 8.3

1.4
14.4
Forward Rate of Return (Yacktman) 11.69
ICUI's Forward Rate of Return (Yacktman) is ranked higher than
84% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.95 vs. ICUI: 11.69 )
ICUI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -2.1   Max: 27.2
Current: 11.69

-2.1
27.2

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:IC7.Germany
ICU Medical, Inc. is a Delaware Corporation founded in 1984. The Company is engaged in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications. Its products improve patient outcomes by helping to prevent bloodstream infections and protect healthcare workers and patients from exposure to infectious diseases or hazardous drugs and monitoring continuous cardiac output of critical care patients. The Company's complete product line includes custom infusion systems, closed delivery systems for hazardous drugs, needle free infusion connectors, catheters and cardiac monitoring systems. Its products are used in hospitals and alternate medical sites in more than 50 countries throughout the world. Its products are categorized into three main product lines: Infusion Therapy, Critical Care and Oncology. Infusion Therapy: I.V. therapy lines, used in hospitals and ambulatory clinics, consist of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patient's vein. The tube typically has several injection ports or Y-sites (conventionally, entry tubes covered by rubber caps) to which a secondary I.V. line can be connected to permit constant intravenous administration of medications, fluids and nutrients, and to allow instantaneous intravenous administration of emergency medication. Critical Care: Critical care products are used to monitor vital signs as well as specific physiological functions of key organ systems and Oncology: Oncology products are used to prepare and deliver hazardous medications such as those used in chemotherapy which, if released, can have harmful effects to the healthcare worker and environment. Manufacturing of its products involves injection molding of plastic and silicone parts, manual and automated assembly of the molded plastic parts, needles and other components, quality control inspection, packaging and sterilization. The Company currently sells all of its products to I.V. product manufacturers, independent distributors and direct sales to the end user. It competes with other manufacturers of closed system transfer devices for the safe handling of oncology drugs, notably Becton Dickinson, CareFusion and B Braun. The Company's products are subject to clearance by the United States Food and Drug Administration ("FDA") under a number of statutes including the Food Drug and Cosmetics Act ("FDC Act").
» More Articles for ICUI

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: GE, ICUI, OPK, CLMS, AHH Mar 10 2014 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 2,388 Shares Nov 29 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 18,831 Shares Nov 24 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,406 Shares Nov 15 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 3,691 Shares Nov 09 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,500 Shares Nov 08 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 5,684 Shares Nov 05 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 1,000 Shares Nov 03 2010 
ICU Medical Inc. (ICUI) Chairman, 10% Owner George A Lopez sells 9,496 Shares Nov 02 2010 
ICU Medical Inc. Reports Operating Results (10-Q) Oct 22 2010 

More From Other Websites
ICU MEDICAL INC/DE Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Jul 25 2014
ICU Medical, Inc. Announces Time of Second Quarter 2014 Earnings Call Jul 21 2014
ICU Medical, Inc. Announces Time of Second Quarter 2014 Earnings Call Jul 21 2014
Medtronic's MiniMed Insulin Pump: A Key to Type 2 Diabetes Cure Jul 03 2014
Abaxis' VetScan Test Kit Wins USDA Approval Jul 02 2014
PetMed Raised to Buy on Solid Growth Strategies Jul 01 2014
Conatus Pharmaceuticals Inc. (CNAT) Gains: Stock Up 8.71% Jul 01 2014
NICE Guidelines to Boost Boston Scientific's Rhythm Management Jun 27 2014
Haemonetics Suffers on Dismal Q4, Poor FY15 Outlook Jun 27 2014
Medtronic's Cardiac Monitor Boosts AF Detection in Stroke Patients Jun 26 2014
Bio-Rad Unveils Vitamin-D Test in International Market Jun 24 2014
Safeway: No More Upside Related to Impending Merger Jun 24 2014
Walgreens Misses on Q3 Earnings, Fresh Fiscal 2016 View Awaited Jun 24 2014
Greatbatch Touches a New 52-Week High Jun 23 2014
CareFusion Reaches a New 52-Week High Jun 23 2014
Medtronic's Micra Pacemaker Spells Success in Prelim Study Jun 20 2014
athenahealth Leads in Meaningful Use Stage 2 Attestations Jun 20 2014
Medtronic's Adaptive CRT Helps Fight Atrial Fibrillation Jun 19 2014
New Study Shows ICU Medical's MicroClave and Neutron Needlefree IV Connectors Have "Significantly... Jun 18 2014
FDA Nod for Alere's Influenza A & B Test Jun 17 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide